Response to the article by Kwak et al entitled "No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin".

MLA

Greenlund, Lindsey Katelyn, et al. “Response to the Article by Kwak et Al Entitled ‘No Increased Incidence of Clostridium Difficile Infection among Patients with Hidradenitis Suppurativa Treated with Systemic Clindamycin.’” Journal of the American Academy of Dermatology, vol. 87, no. 1, July 2022, pp. e17–18. EBSCOhost, https://doi.org/10.1016/j.jaad.2022.02.052.

APA

Greenlund, L. K., Herzog, C., Drekonja, D., & Goldfarb, N. (2022). Response to the article by Kwak et al entitled “No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin.” Journal of the American Academy of Dermatology, 87(1), e17–e18. https://doi.org/10.1016/j.jaad.2022.02.052

Chicago

Greenlund, Lindsey Katelyn, Claire Herzog, Dimitri Drekonja, and Noah Goldfarb. 2022. “Response to the Article by Kwak et Al Entitled ‘No Increased Incidence of Clostridium Difficile Infection among Patients with Hidradenitis Suppurativa Treated with Systemic Clindamycin.’” Journal of the American Academy of Dermatology 87 (1): e17–18. doi:10.1016/j.jaad.2022.02.052.